Circulating miRNAs in acute new-onset atrial fibrillation and their target mRNA network

• Autor(a) principal: Sousa, Júlio César Vieira de
• Data de Publicação: 2018
• Outros Autores: Silva, Ananília Medeiros Gomes da, Araújo, Jessica Nayara Gomes de, Oliveira, Katiane Macedo de, Novaes, Ana Eloisa Melo, Lopes, Mariana Borges, Araújo Filho, Antonio Amorim de, Luchessi, Andre Ducati, Rezende, Adriana Augusto de, Hirata, Mario Hiroyuki, Silbiger, Vivian Nogueira
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRN
• Texto Completo: https://repositorio.ufrn.br/handle/123456789/54320; https://doi.org/10.1111/jce.13612
• topic: acute new-onset AF; atrial fibrillation; mRNA

MicroRNAs (miRNAs) are involved in the pathogenesis of atrial fibrillation (AF), acting on development and progression. Our pilot study investigated the expression of six miRNAs and their miRNA–mRNA interactions in patients with acute new-onset AF, well-controlled AF, and normal sinus rhythm (controls). Methods and results Plasma of acute new-onset AF patients (n = 5) was collected in the emergency room when patients presented with irregular and fast-atrial fibrillation rhythm. Samples from well-controlled AF (n = 16) and control (n = 15) patients were collected during medical appointments following an ECG. Expression of miR-21, miR-133a, miR-133b, miR-150, miR-328, and miR-499 was analyzed by real-time PCR. Ingenuity Pathway Analysis and the TargetScan database identified the top 30 mRNA targets of these miRNA, seeking the miRNA–mRNA interactions in cardiovascular process. Increased expression of miR-133b (1.4-fold), miR-328 (2.0-fold), and miR-499 (2.3-fold) was observed in patients with acute new-onset AF, compared with well-controlled AF and control patients. Decreased expression of miR-21 was seen in patients with well-controlled AF compared to those with acute new-onset AF and controls (0.6-fold). The miRNA-mRNA interaction demonstrated that SMAD7 and FASLG genes were the targets of miR-21, miR-133b, and miR-499 and were directly related to AF, being involved in apoptosis and fibrosis. Conclusion: The miRNAs had different expression profiles dependent on the AF condition, with higher expression in the acute new-onset AF than well-controlled AF. Clinically, this may contribute to an effective assessment for patients, leading to early detection of AF and monitoring to reduce the risk of other serious cardiovascular events.